NHS diabetes drive sees public lose ‘weight of 43 ambulances’
89,604 people have now finished the programme, marking the service as a world first of its kind to have achieved a full national roll-out.
Read Moreby Anna Smith | Jan 2, 2020 | News | 0
89,604 people have now finished the programme, marking the service as a world first of its kind to have achieved a full national roll-out.
Read Moreby Anna Smith | Sep 5, 2019 | News | 0
The news comes after Cancer Research UK found that obesity causes more cases of certain cancers than smoking.
Read Moreby Selina McKee | Jun 25, 2018 | News | 0
Novo Nordisk has announced new data showing that its once-weekly glucagon-like peptide 1 (GLP-1) receptor agonist Ozempic provided greater weight reductions than Eli Lilly’s rival drug Trulicity in adults with type II diabetes.
Read Moreby Selina McKee | Mar 15, 2018 | News | 0
According to NHS England more than half of patients routinely attending sessions offered as part of its diabetes prevention programme have achieved weight losss equivalent to nearly 15 double cheeseburgers.
Read Moreby Selina McKee | Dec 12, 2017 | News | 0
An appeal to get NHS funding for Mysimba as a means for controlling weight has failed, with cost-regulators publishing final guidelines rejecting the drug.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
